Exelixis reported $101.56M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Akebia Therapeutics AKBA:US $ 46.36M 4.71M
Amgen AMGN:US $ 1.31B 79M
AstraZeneca AZN:LN 2.99B 412M
Bayer BAYN:GR 3.77B 19M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Cytokinetics CYTK:US $ 26.2M 5M
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Eisai 4523:JP 79.76B 5.03B
Eli Lilly And LLY:US $ 1.58B 107.8M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Exelixis EXEL:US $ 101.56M 3.06M
Genmab GEN:DC 306M 42M
Glaxosmithkline GSK:US 2.5B 6M
Immunogen IMGN:US $ 10.3M 569K
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Macrogenics MGNX:US $ 17.16M 1.93M
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Moderna Inc MRNA:US 168M 47M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Takeda 4502:JP 212.01B 7.83B
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Xencor XNCR:US $ 10.37M 1.51M
YTE INCY:US $ 190.7M 21.84M